288 related articles for article (PubMed ID: 25164762)
1. Synthesis and biological evaluation of glaucocalyxin A derivatives as potential anticancer agents.
Yang J; Liu Y; Xue C; Yu W; Zhang J; Qiao C
Eur J Med Chem; 2014 Oct; 86():235-41. PubMed ID: 25164762
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and Cytotoxicity Assessment of Novel 7-O- and 14-O-Derivatives of Glaucocalyxin A.
Liu HC; Qiao LM; Zheng W; Xiang ZB; Chen HS; Yu SC; Zhang DZ; Wang T; Zhang YF; Jin YS
Anticancer Agents Med Chem; 2020; 20(10):1241-1249. PubMed ID: 32116205
[TBL] [Abstract][Full Text] [Related]
3. D-ring modified novel isosteviol derivatives: design, synthesis and cytotoxic activity evaluation.
Zhang T; Lu LH; Liu H; Wang JW; Wang RX; Zhang YX; Tao JC
Bioorg Med Chem Lett; 2012 Sep; 22(18):5827-32. PubMed ID: 22901386
[TBL] [Abstract][Full Text] [Related]
4. Novel anticancer oridonin derivatives possessing a diazen-1-ium-1,2-diolate nitric oxide donor moiety: Design, synthesis, biological evaluation and nitric oxide release studies.
Xu S; Wang G; Lin Y; Zhang Y; Pei L; Yao H; Hu M; Qiu Y; Huang Z; Zhang Y; Xu J
Bioorg Med Chem Lett; 2016 Jun; 26(12):2795-2800. PubMed ID: 27158140
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of novel oridonin analogues as potent anticancer agents.
Shen QK; Chen ZA; Zhang HJ; Li JL; Liu CF; Gong GH; Quan ZS
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):324-333. PubMed ID: 29303372
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, cytotoxicity and antiplasmodial activity of novel ent-kaurane derivatives.
Batista R; García PA; Castro MA; Miguel Del Corral JM; Speziali NL; de P Varotti F; de Paula RC; García-Fernández LF; Francesch A; San Feliciano A; de Oliveira AB
Eur J Med Chem; 2013 Apr; 62():168-76. PubMed ID: 23353738
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and cytotoxic activity of MOM-ether analogs of isosteviol.
Malki A; Laha R; Bergmeier SC
Bioorg Med Chem Lett; 2014 Feb; 24(4):1184-7. PubMed ID: 24444475
[TBL] [Abstract][Full Text] [Related]
8. Effective enmein-type mimics of clinical candidate HAO472: Design, synthesis and biological evaluation.
Hu X; Bai Z; Qiao J; Li H; Xu S; Wang X; Xu Y; Xu J; Hua H; Li D
Eur J Med Chem; 2019 Jun; 171():169-179. PubMed ID: 30921757
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, cytotoxic activity evaluation and HQSAR study of novel isosteviol derivatives as potential anticancer agents.
Liu CJ; Yu SL; Liu YP; Dai XJ; Wu Y; Li RJ; Tao JC
Eur J Med Chem; 2016 Jun; 115():26-40. PubMed ID: 26994841
[TBL] [Abstract][Full Text] [Related]
10. Design and stereoselective synthesis of novel isosteviol-fused pyrazolines and pyrazoles as potential anticancer agents.
Zhu SL; Wu Y; Liu CJ; Wei CY; Tao JC; Liu HM
Eur J Med Chem; 2013 Jul; 65():70-82. PubMed ID: 23693151
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, and evaluation of in vitro and in vivo anticancer activity of 14-substituted oridonin analogs: A novel and potent cell cycle arrest and apoptosis inducer through the p53-MDM2 pathway.
Shen QK; Deng H; Wang SB; Tian YS; Quan ZS
Eur J Med Chem; 2019 Jul; 173():15-31. PubMed ID: 30981113
[TBL] [Abstract][Full Text] [Related]
12. The conversion of oridonin to spirolactone-type or enmein-type diterpenoid: synthesis and biological evaluation of ent-6,7-seco-oridonin derivatives as novel potential anticancer agents.
Wang L; Li D; Xu S; Cai H; Yao H; Zhang Y; Jiang J; Xu J
Eur J Med Chem; 2012 Jun; 52():242-50. PubMed ID: 22483090
[TBL] [Abstract][Full Text] [Related]
13. Hydrogen sulfide donating ent-kaurane and spirolactone-type 6,7-seco-ent-kaurane derivatives: Design, synthesis and antiproliferative properties.
Li H; Gao X; Huang X; Wang X; Xu S; Uchita T; Gao M; Xu J; Hua H; Li D
Eur J Med Chem; 2019 Sep; 178():446-457. PubMed ID: 31202992
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of novel Jiyuan Oridonin A-1,2,3-triazole-azole derivatives as antiproliferative agents.
Ke Y; Liang JJ; Hou RJ; Li MM; Zhao LF; Wang W; Liu Y; Xie H; Yang RH; Hu TX; Wang JY; Liu HM
Eur J Med Chem; 2018 Sep; 157():1249-1263. PubMed ID: 30193221
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of spirolactone-type diterpenoid derivatives from kaurene-type oridonin with improved antiproliferative effects and their apoptosis-inducing activity in human hepatoma Bel-7402 cells.
Li D; Cai H; Jiang B; Liu G; Wang Y; Wang L; Yao H; Wu X; Sun Y; Xu J
Eur J Med Chem; 2013 Jan; 59():322-8. PubMed ID: 23274570
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, characterization and
Qi XX; Wang PP; Cui LT; Jin M; Zhao LX; Li G
J Asian Nat Prod Res; 2024 Jul; 26(7):812-823. PubMed ID: 38477295
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of novel 1-O- and 14-O-derivatives of oridonin as potential anticancer drug candidates.
Xu J; Yang J; Ran Q; Wang L; Liu J; Wang Z; Wu X; Hua W; Yuan S; Zhang L; Shen M; Ding Y
Bioorg Med Chem Lett; 2008 Aug; 18(16):4741-4. PubMed ID: 18644718
[TBL] [Abstract][Full Text] [Related]
18. Design and Synthesis of C-19 Isosteviol Derivatives as Potent and Highly Selective Antiproliferative Agents.
Luan T; Cao LH; Deng H; Shen QK; Tian YS; Quan ZS
Molecules; 2018 Dec; 24(1):. PubMed ID: 30598028
[TBL] [Abstract][Full Text] [Related]
19. Enmein-type diterpenoid analogs from natural kaurene-type oridonin: Synthesis and their antitumor biological evaluation.
Li D; Xu S; Cai H; Pei L; Zhang H; Wang L; Yao H; Wu X; Jiang J; Sun Y; Xu J
Eur J Med Chem; 2013 Jun; 64():215-21. PubMed ID: 23644204
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of Oridonin Derivatives via Mizoroki-Heck Reaction and Click Chemistry for Cytotoxic Activity.
Hou W; Fan Q; Su L; Xu H
Anticancer Agents Med Chem; 2019; 19(7):935-947. PubMed ID: 30657049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
